Veru VERU
NASDAQ VERU
$2.64 +0.06 (+2.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Veru (VERU) Cash from Investing Activities (2010 - 2026)

Veru (VERU) posted quarterly Cash from Investing Activities of $3.5 million for Q1 2026, up 206.69% year-over-year from $1.1 million in Q1 2025, and down 43.91% quarter-over-quarter from $6.3 million in Q3 2025.

Veru (VERU) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Veru (VERU) has reported Cash from Investing Activities for 17 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 206.69% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $10.3 million (down 44.72% YoY), while the FY2025 annual figure was $25.1 million, up 17096.01% from the prior year.
  • Cash from Investing Activities eased to $3.5 million in Q1 2026 per VERU's latest filing, from $6.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $17.2 million in Q4 2024 and bottomed at -$285565.0 in Q4 2022.
  • Historically, Cash from Investing Activities has averaged $2.5 million across 5 years, with a median of $474064.0 in 2025.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 3655.58% — and 2025, when it soared 4672.43%.
  • Veru's Cash from Investing Activities stood at -$285565.0 in 2022, then surged by 375.64% to $787126.0 in 2023, then jumped by 2090.92% to $17.2 million in 2024, then plunged by 63.61% to $6.3 million in 2025, then plunged by 43.91% to $3.5 million in 2026.
  • Business Quant data shows VERU's Cash from Investing Activities at $3.5 million in Q1 2026, $6.3 million in Q3 2025, and $474064.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 329.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -49.35 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -363.46 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3.17 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 24.51 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -229.72 Mn
10 Veru 60.85 Mn 35.06 Mn - 1.80 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.80 Mn
Jun 30, 2026 1.80 Mn
Mar 31, 2026 3.52 Mn
Mar 31, 2026 3.52 Mn
Sep 30, 2025 6.28 Mn
Sep 30, 2025 6.28 Mn
Jun 30, 2025 474,064.00
Jun 30, 2025 474,064.00
Mar 31, 2025 1.15 Mn
Mar 31, 2025 1.15 Mn
Dec 31, 2024 17.25 Mn
Dec 31, 2024 17.25 Mn
Sep 30, 2024 131,500.00
Sep 30, 2024 131,500.00
Jun 30, 2024 55,370.00
Jun 30, 2024 55,370.00
Mar 31, 2024 -40,656.00
Mar 31, 2024 -40,656.00
Sep 30, 2023 787,126.00
Sep 30, 2023 787,126.00